{"date": "2020/02/14", "journal": "The Lancet", "authors": "Xiaoying Gu, Bin Cao", "title": "Full spectrum of COVID-19 severity still being depicted \u2013 Authors' reply", "type": "Correspondence", "abstract": "Authors\u2019 reply\nZhou Xu and colleagues point out that\nmortality, which should be referred\ncorrectly and more clearly as case\nfatality ratio, among the first 41 cases\nwith laboratory-confirmed 2019\nnovel coronavirus disease (COVID-19;\npreviously known as 2019-nCoV) was\nmisleading in our Article.1", "text": "Authors\u2019 replyZhou Xu and colleagues point out thatmortality, which should be referredcorrectly and more clearly as casefatality ratio, among the first 41 caseswith laboratory-confirmed 2019novel coronavirus disease (COVID-19;previously known as 2019-nCoV) wasmisleading in our Article.1We definitely agree that the casefatality ratio among the first 41 casescannot represent the case fatality ratioof the full disease spectrum duringthe outbreak of COVID-19. From theperspective of case detection, thereasons for the inconsistency betweenthe case fatality ratio reported inour Article1 and data that havebecome available since publicationof our Article1 were clearly clarifiedin advance in the comment byChen Wang and colleagues.2 Patientswith the most severe symptomswere paid attention to during theearly stages of the outbreak becauseof limited resources to detect severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Fromthe perspective of treatment, eventhe most up-to-date case fatality ratiois expected to decrease as diagnosisand treatment procedure for patientswith pneumonia who are infectedwith SARS-CoV-2 is improving,3potential drugs to treat COVID-19are being evaluated for eficacy andsafety in ongoing clinical trials,4,5and management is becoming moreintense, not only for patients withsevere infection but also for those withmoderate, mild, or even asymptomaticinfection.Without denying the limitations ofour study1 at the time of publication,we still hope our results provided auseful depiction of clinical featuresof SARS-CoV-2 infection at thevery early stage of the outbreakand during progression of disease.Intense and continuous efforts areindeed needed for medical workersand researchers all over the world toget the full picture of the spectrum ofdisease severity of COVID-19 and toovercome the huge health challenge.", "ref_list": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "ref_authors": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "fir_para": "Authors\u2019 reply\nZhou Xu and colleagues point out that\nmortality, which should be referred\ncorrectly and more clearly as case\nfatality ratio, among the first 41 cases\nwith laboratory-confirmed 2019\nnovel coronavirus disease (COVID-19;\npreviously known as 2019-nCoV) was\nmisleading in our Article.1", "one_words_summarize": "Authors\u2019 replyZhou Xu and colleagues point out thatmortality, which should be referredcorrectly and more clearly as casefatality ratio, among the first 41 caseswith laboratory-confirmed 2019novel coronavirus disease (COVID-19;previously known as 2019-nCoV) wasmisleading in our Article.1We definitely agree that the casefatality ratio among the first 41 casescannot represent the case fatality ratioof the full disease spectrum duringthe outbreak of COVID-19. From theperspective of case detection, thereasons for the inconsistency betweenthe case fatality ratio reported inour Article1 and data that havebecome available since publicationof our Article1 were clearly clarifiedin advance in the comment byChen Wang and colleagues.2 Patientswith the most severe symptomswere paid attention to during theearly stages of the outbreak becauseof limited resources to detect severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection."}